Header Logo

Connection

THEODORE ROSEN to Humans

Back to Details
This is a "connection" page, showing publications THEODORE ROSEN has written about Humans.
THEODORE ROSEN
Connection Strength
0.599
Humans
  1. The potential impact of ACOG guideline changes on genital melanoma detection rates in females: a retrospective cross-sectional analysis and implications for clinical practice. Arch Dermatol Res. 2025 Feb 19; 317(1):438.
    View in: PubMed
    Score: 0.025
  2. Cutaneous nodules secondary to Mycobacterium avium complex in a patient with human immunodeficiency virus. Dermatol Online J. 2024 Dec 16; 30(6).
    View in: PubMed
    Score: 0.024
  3. Practical Update on Treatment of Oral Candidiasis. J Drugs Dermatol. 2024 Dec 01; 23(12):e186-e190.
    View in: PubMed
    Score: 0.024
  4. The Spread of STDs-A Preventable Public Health Crisis in the United States. Skinmed. 2024; 22(1):11-13.
    View in: PubMed
    Score: 0.023
  5. A case of filgrastim-induced neutrophilic dermatosis of the dorsal hands in a patient with Felty Syndrome. Dermatol Online J. 2023 Dec 15; 29(6).
    View in: PubMed
    Score: 0.023
  6. "The Raven Himself Is Hoarse:" Candida dubliniensis fungemia manifesting as an eschar. Skinmed. 2022; 20(3):213-214.
    View in: PubMed
    Score: 0.021
  7. Future Fungal Fighters in Dermatology: Novel Antifungal Drug Pipeline. J Drugs Dermatol. 2022 May 01; 21(5):496-501.
    View in: PubMed
    Score: 0.020
  8. Public interest in skin lightening across the United States, January 2015-December 2020. J Cosmet Dermatol. 2022 May; 21(5):1931-1935.
    View in: PubMed
    Score: 0.020
  9. Intramuscular lipoma of the scapular region. Dermatol Online J. 2021 Jul 15; 27(7).
    View in: PubMed
    Score: 0.019
  10. Sexually Transmitted Diseases in the COVID-19 Era. Skinmed. 2020; 18(4):210-212.
    View in: PubMed
    Score: 0.018
  11. Unmasking Masks. Skinmed. 2020; 18(3):152-157.
    View in: PubMed
    Score: 0.018
  12. Probable African Tick Bite Fever in the United States. Yale J Biol Med. 2020 03; 93(1):49-54.
    View in: PubMed
    Score: 0.018
  13. Ingenol Mebutate: Expanded Utility J Drugs Dermatol. 2020 Feb 1 j; 19(2):156-161.
    View in: PubMed
    Score: 0.017
  14. What are the ethical and legal considerations when your patient refuses the standard of care? Dermatol Online J. 2019 Aug 15; 25(8).
    View in: PubMed
    Score: 0.017
  15. Indurated erythema of the neck and upper back. Int J Dermatol. 2019 Nov; 58(11):1255-1257.
    View in: PubMed
    Score: 0.017
  16. BRCA1-Associated Protein-1 Tumor Predisposition Syndrome in a Patient With Numerous Basal Cell Carcinomas. Dermatol Surg. 2019 02; 45(2):316-318.
    View in: PubMed
    Score: 0.016
  17. A review of N-acetylcysteine in the treatment of grooming?disorders. Int J Dermatol. 2019 Apr; 58(4):502-510.
    View in: PubMed
    Score: 0.016
  18. Efficacy and Safety of Ozenoxacin Cream for Treatment of Adult and Pediatric Patients With Impetigo: A Randomized Clinical Trial. JAMA Dermatol. 2018 07 01; 154(7):806-813.
    View in: PubMed
    Score: 0.016
  19. Cutaneous leishmaniasis mimicking squamous cell carcinoma. Dermatol Online J. 2017 Jan 15; 23(1).
    View in: PubMed
    Score: 0.014
  20. Tinea and Onychomycosis. Semin Cutan Med Surg. 2016 Jun; 35(6 Suppl):S110-3.
    View in: PubMed
    Score: 0.013
  21. Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action. Semin Cutan Med Surg. 2016 Mar; 35(3 Suppl 3):S51-5.
    View in: PubMed
    Score: 0.013
  22. Concepts in Onychomycosis Treatment and Recurrence Prevention: An Update. Semin Cutan Med Surg. 2016 Mar; 35(3 Suppl 3):S56-9; quiz s61.
    View in: PubMed
    Score: 0.013
  23. Introduction. Semin Cutan Med Surg. 2016 Mar; 35(3 Suppl 3):S47.
    View in: PubMed
    Score: 0.013
  24. Using Topical Antifungal Medications: Instructions for patients. Semin Cutan Med Surg. 2016 Mar; 35(3 Suppl 3):s60.
    View in: PubMed
    Score: 0.013
  25. Assessment of Dermatophytosis Treatment Studies: Interpreting the Data. J Drugs Dermatol. 2015 Oct; 14(10 Suppl):s48-54.
    View in: PubMed
    Score: 0.013
  26. Onychomycosis: epidemiology, diagnosis, and treatment in a changing landscape. J Drugs Dermatol. 2015 Mar; 14(3):223-33.
    View in: PubMed
    Score: 0.012
  27. Prevalence and awareness of actinic keratosis: barriers and opportunities. J Am Acad Dermatol. 2013 Jan; 68(1 Suppl 1):S2-9.
    View in: PubMed
    Score: 0.011
  28. The rate of melanoma transection with various biopsy techniques and the influence of tumor transection on patient survival. J Am Acad Dermatol. 2013 Mar; 68(3):452-8.
    View in: PubMed
    Score: 0.010
  29. Thermotherapy in dermatologic infections. J Am Acad Dermatol. 2010 Jun; 62(6):909-27; quiz 928.
    View in: PubMed
    Score: 0.009
  30. Beyond a decade of 5% imiquimod topical therapy. J Drugs Dermatol. 2009 May; 8(5):467-74.
    View in: PubMed
    Score: 0.008
  31. Azithromycin as an alternative rosacea therapy when tetracyclines prove problematic. J Drugs Dermatol. 2008 Sep; 7(9):898-9.
    View in: PubMed
    Score: 0.008
  32. Etanercept therapy for silicone granuloma. J Drugs Dermatol. 2006 Oct; 5(9):894-6.
    View in: PubMed
    Score: 0.007
  33. Sexually transmitted diseases 2006: a dermatologist's view. Cleve Clin J Med. 2006 Jun; 73(6):537-8, 542, 544-5 passim.
    View in: PubMed
    Score: 0.007
  34. Cutaneous amebiasis in a child and review of the literature. Pediatr Dermatol. 2006 May-Jun; 23(3):231-4.
    View in: PubMed
    Score: 0.007
  35. Update on treating uncomplicated skin and skin structure infections. J Drugs Dermatol. 2005 Nov-Dec; 4(6 Suppl):s9-14.
    View in: PubMed
    Score: 0.006
  36. A review of the efficacy of complementary and alternative Medicines in managing Pruritus. Arch Dermatol Res. 2024 Dec 07; 317(1):81.
    View in: PubMed
    Score: 0.006
  37. Advances in Technology for Melanoma Diagnosis and Prognosis: An Expert Consensus Panel. J Drugs Dermatol. 2024 09 01; 23(9):774-781.
    View in: PubMed
    Score: 0.006
  38. Dermatologic fungal neglected tropical diseases-Part I. Epidemiology and clinical features. J Am Acad Dermatol. 2025 Jun; 92(6):1189-1206.
    View in: PubMed
    Score: 0.006
  39. Dermatologic fungal neglected tropical diseases-Part II. Management and morbidity. J Am Acad Dermatol. 2025 Jun; 92(6):1209-1224.
    View in: PubMed
    Score: 0.006
  40. Rosacea Core Domain Set for Clinical Trials and Practice: A Consensus Statement. JAMA Dermatol. 2024 Jun 01; 160(6):658-666.
    View in: PubMed
    Score: 0.006
  41. Factors Influencing Patients' Confidence in Their Mohs Surgeons. Dermatol Surg. 2024 04 01; 50(4):381-383.
    View in: PubMed
    Score: 0.006
  42. Therapeutic Approaches and Special Considerations for Treating Molluscum Contagiosum. J Drugs Dermatol. 2021 Nov 01; 20(11):1185-1190.
    View in: PubMed
    Score: 0.005
  43. Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients With Impetigo: Pooled Analysis of Phase 3 Clinical Trials. J Drugs Dermatol. 2018 Oct 01; 17(10):1051-1057.
    View in: PubMed
    Score: 0.004
  44. A Phase 2 Controlled Study of SB206, a Topical Nitric Oxide-Releasing Drug for Extragenital Wart Treatment. J Drugs Dermatol. 2018 Oct 01; 17(10):1100-1105.
    View in: PubMed
    Score: 0.004
  45. Approach to moderately dysplastic nevi with positive histologic margins. J Am Acad Dermatol. 2017 11; 77(5):e147.
    View in: PubMed
    Score: 0.004
  46. Reply: Do moderately dysplastic nevi with positive histologic margins need to be reexcised? J Am Acad Dermatol. 2017 09; 77(3):e85.
    View in: PubMed
    Score: 0.004
  47. Integrating Skin Cancer-Related Technologies into Clinical Practice. Dermatol Clin. 2017 Oct; 35(4):565-576.
    View in: PubMed
    Score: 0.004
  48. Recurrence of moderately dysplastic nevi with positive histologic margins. J Am Acad Dermatol. 2017 Mar; 76(3):527-530.
    View in: PubMed
    Score: 0.003
  49. Porokeratosis of Mibelli: Successful treatment with 5 percent topical imiquimod and topical 5 percent 5-fluorouracil. Dermatol Online J. 2010 Dec 15; 16(12):10.
    View in: PubMed
    Score: 0.002
  50. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cycles. J Am Acad Dermatol. 2010 Apr; 62(4):573-81.
    View in: PubMed
    Score: 0.002
  51. A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions. J Drugs Dermatol. 2007 Oct; 6(10):1001-8.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.